Sep 30, 2026 07:19AM
Sep 29, 2026 07:31AM
Aug 6, 2026 07:10AM
Jun 9, 2026 07:01AM
May 26, 2026 10:48AM
May 12, 2026 06:54AM
Apr 30, 2026 07:33AM Cartesian Therapeutics (RNAC) Misses Q1 EPS by 146c
Mar 9, 2026 03:13PM
Mar 9, 2026 01:51PM
Mar 9, 2026 10:56AM
Jan 9, 2026 08:05AM
Nov 19, 2025 06:40AM
Nov 14, 2025 06:45AM
Nov 6, 2025 08:11AM Cartesian Therapeutics (RNAC) Misses Q3 EPS by 138c
Oct 21, 2025 07:04AM
Oct 8, 2025 07:04AM
Aug 7, 2025 08:07AM
Jul 9, 2025 06:36AM
Jun 2, 2025 06:55AM
May 30, 2025 12:12PM
May 30, 2025 07:01AM Cartesian Therapeutics (RNAC) Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
May 8, 2025 04:29PM
Apr 8, 2025 07:01AM
Mar 17, 2025 06:45AM
Mar 17, 2025 06:39AM
Jan 28, 2025 06:39AM
Dec 19, 2024 05:55AM
Dec 13, 2024 04:20PM Cartesian Therapeutics (RNAC) Files for 11.39M Share Offering by Selling Stockholders
Dec 13, 2024 04:18PM
Dec 4, 2024 06:48AM
Dec 3, 2024 06:01AM
Oct 15, 2024 07:03AM
Sep 25, 2024 02:34PM
Sep 20, 2024 04:20PM
Sep 13, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Cartesian Therapeutics (RNAC)
Sep 9, 2024 04:15PM
Sep 9, 2024 07:03AM
Sep 4, 2024 07:30AM
Sep 3, 2024 07:05AM
Aug 9, 2024 07:33AM
Aug 8, 2024 07:23AM
Aug 6, 2024 05:31AM TD Cowen Starts Cartesian Therapeutics (RNAC) at Buy
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM
Jul 2, 2024 04:07PM
Jul 2, 2024 11:27AM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:30AM Cartesian Therapeutics (RNAC) Reports Positive Topline Results from Phase 2b Trial of Descartes-08

479,039 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All